Free Trial
→ Trump’s betrayal exposed (From Porter & Company) (Ad) Buy GEAR Stock  Free GEAR Stock Alerts

Revelyst (GEAR) Financials

Revelyst logo
$20.08 +0.86 (+4.47%)
As of 01/3/2025
Compare
Annual Income Statements for Revelyst

Annual Income Statements for Revelyst

This table shows Revelyst's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 78 -337 -242
Consolidated Net Income / (Loss)		 78 -337 -242
Net Income / (Loss) Continuing Operations		 78 -337 -242
Total Pre-Tax Income 		102 -366 -265
Total Operating Income		 102 -368 -263
Total Gross Profit		 397 377 373
Total Revenue		 1,322 1,339 1,309
Operating Revenue		 1,322 1,339 1,309
Total Cost of Revenue		 925 963 936
Operating Cost of Revenue		 925 963 936
Total Operating Expenses		 295 745 636
Selling, General & Admin Expense		 274 334 375
Research & Development Expense		 21 37 42
Impairment Charge		 0.00 374 219
Total Other Income / (Expense), net		 0.00 2.30 -1.87
Interest & Investment Income		 0.00 0.17 0.12
Other Income / (Expense), net		 0.00 2.12 -1.99
Income Tax Expense		 24 -29 -22
Weighted Average Basic Shares Outstanding		 - - 1K
Weighted Average Diluted Shares Outstanding		 - - 1K
Weighted Average Basic & Diluted Shares Outstanding		 - - 1K

Quarterly Income Statements for Revelyst

This table shows Revelyst's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Net Income / (Loss) Attributable to Common Shareholders		 -5.36 -4.34 -1.96 4.56
Consolidated Net Income / (Loss)		 -5.36 -4.34 -1.29 4.56
Net Income / (Loss) Continuing Operations		 -5.36 -4.34 -1.29 4.56
Total Pre-Tax Income 		-5.80 -5.93 -0.81 4.59
Total Operating Income		 -5.30 -4.80 -1.50 4.32
Total Gross Profit		 95 94 81 98
Total Revenue		 321 333 274 315
Operating Revenue		 321 333 274 315
Total Cost of Revenue		 227 239 193 217
Operating Cost of Revenue		 227 239 193 217
Total Operating Expenses		 100 99 102 94
Selling, General & Admin Expense		 90 88 91 84
Research & Development Expense		 10 10 11 9.51
Other Operating Expenses / (Income)		 - 0.00 - 0.87
Total Other Income / (Expense), net		 -0.50 -1.14 20 0.27
Interest & Investment Income		 0.04 0.04 0.01 0.01
Other Income / (Expense), net		 -0.54 -1.17 20 0.26
Income Tax Expense		 -0.44 -1.59 0.47 0.03
Weighted Average Basic Shares Outstanding		 - - 1K 1K
Weighted Average Diluted Shares Outstanding		 - - 1K 1K
Weighted Average Basic & Diluted Shares Outstanding		 - - 1K 1K

Annual Cash Flow Statements for Revelyst

This table details how cash moves in and out of Revelyst's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents		 5.52 8.26 7.41
Net Cash From Operating Activities		 -31 64 179
Net Cash From Continuing Operating Activities		 -31 64 179
Net Income / (Loss) Continuing Operations		 78 -337 -242
Consolidated Net Income / (Loss)		 78 -337 -242
Depreciation Expense		 16 19 21
Amortization Expense		 26 44 50
Non-Cash Adjustments To Reconcile Net Income		 13 387 229
Changes in Operating Assets and Liabilities, net		 -164 -50 122
Net Cash From Investing Activities		 -559 -774 -30
Net Cash From Continuing Investing Activities		 -559 -774 -30
Purchase of Property, Plant & Equipment		 -13 -13 -14
Acquisitions		 -545 -762 -16
Sale of Property, Plant & Equipment		 0.03 0.04 0.13
Net Cash From Financing Activities		 595 719 -142
Net Cash From Continuing Financing Activities		 595 719 -142
Other Financing Activities, net		 595 719 -142
Effect of Exchange Rate Changes		 -0.07 -0.32 0.30

Quarterly Cash Flow Statements for Revelyst

This table details how cash moves in and out of Revelyst's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Net Change in Cash & Equivalents		 15 -4.52 6.79 -8.00
Net Cash From Operating Activities		 63 36 27 14
Net Cash From Continuing Operating Activities		 63 36 27 14
Net Income / (Loss) Continuing Operations		 -5.36 -4.34 -1.29 4.56
Consolidated Net Income / (Loss)		 -5.36 -4.34 -1.29 4.56
Depreciation Expense		 4.96 5.17 4.31 3.81
Amortization Expense		 13 13 12 12
Non-Cash Adjustments To Reconcile Net Income		 0.39 3.75 -9.35 2.56
Changes in Operating Assets and Liabilities, net		 50 19 21 -9.76
Net Cash From Investing Activities		 -3.33 -3.18 33 2.36
Net Cash From Continuing Investing Activities		 -3.33 -3.18 33 2.36
Purchase of Property, Plant & Equipment		 -3.45 -3.19 -0.50 -3.78
Divestitures		 0.00 - 33 6.14
Net Cash From Financing Activities		 -45 -36 -53 -25
Net Cash From Continuing Financing Activities		 -45 -36 -53 -25
Other Financing Activities, net		 -45 -36 -53 -25
Effect of Exchange Rate Changes		 0.43 -1.13 -0.27 1.14

Annual Balance Sheets for Revelyst

This table presents Revelyst's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Total Assets		 1,951 1,575
Total Current Assets		 664 557
Cash & Equivalents		 16 23
Accounts Receivable		 202 209
Inventories, net		 404 294
Prepaid Expenses		 37 23
Current Deferred & Refundable Income Taxes		 0.00 1.44
Other Current Assets		 5.74 6.71
Plant, Property, & Equipment, net		 71 61
Total Noncurrent Assets		 1,216 956
Goodwill		 380 232
Intangible Assets		 675 569
Other Noncurrent Operating Assets		 161 154
Total Liabilities & Shareholders' Equity		 1,951 1,575
Total Liabilities		 365 341
Total Current Liabilities		 204 206
Accounts Payable		 67 87
Current Employee Benefit Liabilities		 25 20
Other Taxes Payable		 13 13
Other Current Liabilities		 97 87
Total Noncurrent Liabilities		 161 135
Noncurrent Deferred & Payable Income Tax Liabilities		 28 13
Other Noncurrent Operating Liabilities		 134 122
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 1,586 1,234
Total Preferred & Common Equity		 1,586 1,234
Total Common Equity		 1,586 1,234
Accumulated Other Comprehensive Income / (Loss)		 -8.16 -5.61
Other Equity Adjustments		 1,594 1,239

Quarterly Balance Sheets for Revelyst

This table presents Revelyst's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025
Total Assets		 1,527 1,501
Total Current Assets		 541 530
Cash & Equivalents		 30 22
Accounts Receivable		 196 211
Inventories, net		 283 261
Prepaid Expenses		 23 27
Current Deferred & Refundable Income Taxes		 0.69 1.97
Other Current Assets		 7.76 6.43
Plant, Property, & Equipment, net		 49 45
Total Noncurrent Assets		 937 926
Goodwill		 232 232
Intangible Assets		 555 543
Other Noncurrent Operating Assets		 149 151
Total Liabilities & Shareholders' Equity		 1,527 1,501
Total Liabilities		 344 335
Total Current Liabilities		 216 210
Accounts Payable		 85 89
Current Employee Benefit Liabilities		 18 20
Other Taxes Payable		 11 11
Other Current Liabilities		 101 90
Total Noncurrent Liabilities		 127 125
Noncurrent Deferred & Payable Income Tax Liabilities		 13 12
Other Noncurrent Operating Liabilities		 114 113
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 1,183 1,166
Total Preferred & Common Equity		 1,183 1,166
Total Common Equity		 1,183 1,166
Accumulated Other Comprehensive Income / (Loss)		 -5.55 -5.40
Other Equity Adjustments		 1,188 1,171

Annual Metrics and Ratios for Revelyst

This table displays calculated financial ratios and metrics derived from Revelyst's official financial filings.

Metric 2022 2023 2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 1.28% -2.28%
EBITDA Growth		 0.00% -309.99% 35.87%
EBIT Growth		 0.00% -457.36% 27.64%
NOPAT Growth		 0.00% -428.80% 28.60%
Net Income Growth		 0.00% -529.54% 28.03%
EPS Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% 306.34% 180.83%
Free Cash Flow Firm Growth		 0.00% 0.00% 109.59%
Invested Capital Growth		 0.00% 0.00% -22.88%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 30.05% 28.13% 28.52%
EBITDA Margin		 10.92% -22.63% -14.85%
Operating Margin		 7.74% -27.49% -20.08%
EBIT Margin		 7.74% -27.33% -20.24%
Profit (Net Income) Margin		 5.93% -25.14% -18.51%
Tax Burden Percent		 76.52% 92.02% 91.52%
Interest Burden Percent		 100.00% 99.95% 99.96%
Effective Tax Rate		 23.48% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -32.83% -13.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 983.37% 289.59%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -9.64% -3.95%
Return on Equity (ROE)		 0.00% -42.46% -17.19%
Cash Return on Invested Capital (CROIC)		 0.00% -232.83% 12.60%
Operating Return on Assets (OROA)		 0.00% -18.76% -15.03%
Return on Assets (ROA)		 0.00% -17.26% -13.75%
Return on Common Equity (ROCE)		 0.00% -42.46% -17.19%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -21.23% -19.64%
Net Operating Profit after Tax (NOPAT)		 78 -258 -184
NOPAT Margin		 5.93% -19.24% -14.06%
Net Nonoperating Expense Percent (NNEP)		 0.00% -1,016.20% -302.82%
Return On Investment Capital (ROIC_SIMPLE)		 - -16.25% -14.91%
Cost of Revenue to Revenue		 69.95% 71.87% 71.48%
SG&A Expenses to Revenue		 20.70% 24.93% 28.67%
R&D to Revenue		 1.61% 2.74% 3.21%
Operating Expenses to Revenue		 22.31% 55.62% 48.60%
Earnings before Interest and Taxes (EBIT)		 102 -366 -265
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 144 -303 -194
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 0.00 -0.01 -0.01
Leverage Ratio		 0.00 1.23 1.25
Compound Leverage Factor		 0.00 1.23 1.25
Debt to Total Capital		 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 0.00 3.26 2.70
Quick Ratio		 0.00 1.07 1.13
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -1,828 175
Operating Cash Flow to CapEx		 -236.65% 497.39% 1,290.60%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.69 0.74
Accounts Receivable Turnover		 0.00 6.64 6.36
Inventory Turnover		 0.00 2.38 2.68
Fixed Asset Turnover		 0.00 18.77 19.71
Accounts Payable Turnover		 0.00 14.45 12.18
Days Sales Outstanding (DSO)		 0.00 55.01 57.36
Days Inventory Outstanding (DIO)		 0.00 153.05 136.03
Days Payable Outstanding (DPO)		 0.00 25.26 29.97
Cash Conversion Cycle (CCC)		 0.00 182.80 163.41
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 1,570 1,211
Invested Capital Turnover		 0.00 1.71 0.94
Increase / (Decrease) in Invested Capital		 0.00 1,570 -359
Enterprise Value (EV)		 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00
Book Value per Share		 $0.00 $0.00 $1,233,848.00
Tangible Book Value per Share		 $0.00 $0.00 $432,389.00
Total Capital		 0.00 1,586 1,234
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 0.00 -16 -23
Capital Expenditures (CapEx)		 13 13 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 444 328
Debt-free Net Working Capital (DFNWC)		 0.00 460 351
Net Working Capital (NWC)		 0.00 460 351
Net Nonoperating Expense (NNE)		 -0.00 79 58
Net Nonoperating Obligations (NNO)		 0.00 -16 -23
Total Depreciation and Amortization (D&A)		 42 63 70
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 33.19% 25.07%
Debt-free Net Working Capital to Revenue		 0.00% 34.35% 26.82%
Net Working Capital to Revenue		 0.00% 34.35% 26.82%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 1K
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 1K
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 1K
Normalized Net Operating Profit after Tax (NOPAT)		 78 4.35 -31
Normalized NOPAT Margin		 5.93% 0.32% -2.36%
Pre Tax Income Margin		 7.74% -27.31% -20.23%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Revelyst

This table displays calculated financial ratios and metrics derived from Revelyst's official financial filings.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.00% -14.69% -5.36%
EBITDA Growth		 0.00% 0.00% 195.88% 76.76%
EBIT Growth		 0.00% 0.00% 409.70% 176.67%
NOPAT Growth		 0.00% 0.00% 71.64% 227.79%
Net Income Growth		 0.00% 0.00% 76.00% 204.93%
EPS Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% 0.00% -57.43% -62.33%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 3.54% 0.00% 14.86%
EBITDA Q/Q Growth		 0.00% 0.04% 0.00% -40.24%
EBIT Q/Q Growth		 0.00% -2.28% 0.00% -74.68%
NOPAT Q/Q Growth		 0.00% 9.44% 0.00% 508.12%
Net Income Q/Q Growth		 0.00% 18.96% 0.00% 454.28%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% -42.80% 0.00% -49.38%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 1.23%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -0.77%
Profitability Metrics		 - - - -
Gross Margin		 29.47% 28.17% 29.68% 31.21%
EBITDA Margin		 3.66% 3.54% 12.70% 6.61%
Operating Margin		 -1.65% -1.44% -0.55% 1.37%
EBIT Margin		 -1.82% -1.79% 6.59% 1.45%
Profit (Net Income) Margin		 -1.67% -1.30% -0.47% 1.45%
Tax Burden Percent		 92.44% 73.17% 157.99% 99.26%
Interest Burden Percent		 99.28% 99.38% -4.50% 100.26%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.74%
Return on Invested Capital (ROIC)		 0.00% 0.00% -0.84% 2.96%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.74% 0.52%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% -0.02% -0.01%
Return on Equity (ROE)		 0.00% 0.00% -0.86% 2.95%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 5.45% 1.20%
Return on Assets (ROA)		 0.00% 0.00% -0.39% 1.20%
Return on Common Equity (ROCE)		 0.00% 0.00% -0.86% 2.95%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -20.14% -19.67%
Net Operating Profit after Tax (NOPAT)		 -3.71 -3.36 -1.05 4.29
NOPAT Margin		 -1.15% -1.01% -0.38% 1.36%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% -1.58% 2.44%
Return On Investment Capital (ROIC_SIMPLE)		 - - -0.09% 0.37%
Cost of Revenue to Revenue		 70.53% 71.83% 70.32% 68.79%
SG&A Expenses to Revenue		 27.89% 26.52% 33.29% 26.54%
R&D to Revenue		 3.22% 3.10% 3.84% 3.02%
Operating Expenses to Revenue		 31.12% 29.61% 37.12% 29.84%
Earnings before Interest and Taxes (EBIT)		 -5.84 -5.97 18 4.58
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 12 12 35 21
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 -0.03 -0.02
Leverage Ratio		 0.00 0.00 1.29 1.29
Compound Leverage Factor		 0.00 0.00 -0.06 1.29
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 0.00 2.50 2.52
Quick Ratio		 0.00 0.00 1.04 1.11
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -1,154 -1,140
Operating Cash Flow to CapEx		 1,896.75% 1,134.73% 5,423.43% 359.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.00 0.83 0.83
Accounts Receivable Turnover		 0.00 0.00 6.44 5.89
Inventory Turnover		 0.00 0.00 3.19 3.36
Fixed Asset Turnover		 0.00 0.00 25.62 27.39
Accounts Payable Turnover		 0.00 0.00 10.59 9.90
Days Sales Outstanding (DSO)		 0.00 0.00 56.71 62.00
Days Inventory Outstanding (DIO)		 0.00 0.00 114.58 108.50
Days Payable Outstanding (DPO)		 0.00 0.00 34.47 36.88
Cash Conversion Cycle (CCC)		 0.00 0.00 136.82 133.61
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 0.00 1,153 1,144
Invested Capital Turnover		 0.00 0.00 2.19 2.17
Increase / (Decrease) in Invested Capital		 0.00 0.00 1,153 1,144
Enterprise Value (EV)		 0.00 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00 0.00
Book Value per Share		 $0.00 $0.00 $1,182,818.00 $1,165,913.00
Tangible Book Value per Share		 $0.00 $0.00 $395,612.00 $391,112.00
Total Capital		 0.00 0.00 1,183 1,166
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 0.00 0.00 -30 -22
Capital Expenditures (CapEx)		 3.33 3.18 0.50 3.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 295 298
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 324 320
Net Working Capital (NWC)		 0.00 0.00 324 320
Net Nonoperating Expense (NNE)		 1.65 0.98 0.23 -0.27
Net Nonoperating Obligations (NNO)		 0.00 0.00 -30 -22
Total Depreciation and Amortization (D&A)		 18 18 17 16
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 23.35% 23.96%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 25.71% 25.71%
Net Working Capital to Revenue		 0.00% 0.00% 25.71% 25.71%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 1K 1K
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 1K 1K
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 1K 1K
Normalized Net Operating Profit after Tax (NOPAT)		 -3.71 -3.36 -1.05 4.29
Normalized NOPAT Margin		 -1.15% -1.01% -0.38% 1.36%
Pre Tax Income Margin		 -1.80% -1.78% -0.30% 1.46%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Revelyst's Financials

When does Revelyst's financial year end?

According to the most recent income statement we have on file, Revelyst's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Revelyst's net income changed over the last 2 years?

Revelyst's net income appears to be on an upward trend, with a most recent value of -$242.28 million in 2024, falling from $78.38 million in 2022. The previous period was -$336.66 million in 2023.

What is Revelyst's operating income?
Revelyst's total operating income in 2024 was -$262.87 million, based on the following breakdown:
  • Total Gross Profit: $373.22 million
  • Total Operating Expenses: $636.09 million
How has Revelyst revenue changed over the last 2 years?

Over the last 2 years, Revelyst's total revenue changed from $1.32 billion in 2022 to $1.31 billion in 2024, a change of -1.0%.

How much debt does Revelyst have?

Revelyst's total liabilities were at $341.02 million at the end of 2024, a 6.5% decrease from 2023, and a 6.5% decrease since 2023.

How much cash does Revelyst have?

In the past 1 years, Revelyst's cash and equivalents has ranged from $15.54 million in 2023 to $22.95 million in 2024, and is currently $22.95 million as of their latest financial filing in 2024.

How has Revelyst's book value per share changed over the last 2 years?

Over the last 2 years, Revelyst's book value per share changed from 0.00 in 2022 to 1,233,848.00 in 2024, a change of 123,384,800.0%.

Remove Ads

Related Companies

This page (NYSE:GEAR) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored